New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology. By Rebecca Robbins and Gina Kolata Two treatments being tested ...

A new drug is offering hope and time for patients and their families and doubling the survival rate for one of the most deadly cancers. Donna Husar is grateful for the extra time. In 2020, her husband ...

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan Kettering, ...

Phase 1 study of anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody MK-0482 + pembrolizumab + gemcitabine + nab-paclitaxel (Gem/Nab-P) in patients (pts) with metastatic pancreatic ductal ...